Pfizer and Sun snatch up sterile injectable companies to boost expertise and capacity

The sterile injectables business holds a lot of promise for drugmakers with the manufacturing capabilities to produce the difficult-to-make drugs, so a lot of companies have been buying capacity and expertise around the world. Deals announced Wednesday by Pfizer ($PFE) and Sun Pharma were proof positive of how companies think they can cash in on the generics piece of this sterile injectables market. 

continue to read here